2022 Fellows Courses

Edwards Lifesciences invites you to join Tamim Nazif, MD, as we discuss key considerations of lifetime management of TAVR patients. Today’s patients are living longer and expectations for TAVR have never been higher. Now more than ever, valve durability matters across the entire age spectrum of TAVR-eligible patients. This interactive discussion will focus on the SAPIEN platform, factors for consideration when making a decision for the lifetime management of SAS patients, ACC/AHA Guidelines, shared decision making and key communication points and the latest clinical data, and case review.